Cargando…

Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines

BACKGROUND: Canine mammary tumors (CMTs) are the most common type of cancer found in female dogs. Establishment and evaluation of tumor cell lines can facilitate investigations of the biological mechanisms of cancer. Different cell models are used to investigate genetic, epigenetic, and cellular pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsiao, Yen-Ling, Hsieh, Tai-Zu, Liou, Chian-Jiun, Cheng, Yeong-Hsiang, Lin, Chung-Tien, Chang, Chi-Yao, Lai, Yu-Shen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189743/ https://www.ncbi.nlm.nih.gov/pubmed/25267010 http://dx.doi.org/10.1186/s12917-014-0229-0

Ejemplares similares

Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell lines
por: Levi, Michela, et al.
Publicado: (2021)

Doxorubicin as a Potential Treatment Option in Canine Mammary Tumors
por: Gherman, Madalina Luciana, et al.
Publicado: (2023)

Cytogenetic Evolution of Human Ovarian Cell Lines Associated with Chemoresistance and Loss of Tumorigenicity
por: Struski, Stéphanie, et al.
Publicado: (2003)

Iodine and doxorubicin, a good combination for mammary cancer treatment: antineoplastic adjuvancy, chemoresistance inhibition, and cardioprotection
por: Alfaro, Yunuen, et al.
Publicado: (2013)

Feline mammary carcinoma stem cells are tumorigenic, radioresistant, chemoresistant and defective in activation of the ATM/p53 DNA damage pathway
por: Pang, L.Y., et al.
Publicado: (2013)

Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27
por: BAKIREL, Tülay, et al.
Publicado: (2016)

An epigenetic screening determines BET proteins as targets to suppress self-renewal and tumorigenicity in canine mammary cancer cells
por: Xavier, Pedro L. P., et al.
Publicado: (2019)

The Effects of Piroxicam and Deracoxib on Canine Mammary Tumour Cell Line
por: Üstün Alkan, Fulya, et al.
Publicado: (2012)

Dichloroacetate affects proliferation but not apoptosis in canine mammary cell lines
por: Harting, Tatjana P., et al.
Publicado: (2017)

Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas
por: Michel, Erika, et al.
Publicado: (2012)

Methadone does not potentiate the effect of doxorubicin in canine tumour cell lines
por: Cueni, Claudia, et al.
Publicado: (2020)

Expression of autophagy-related protein beclin-1 in malignant canine mammary tumors
por: Liu, Jing-Lan, et al.
Publicado: (2013)

Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer
por: Zhang, Baotong, et al.
Publicado: (2021)

Induction of oncornavirus-like particles in cell line of canine mammary carcinoma.
por: Watrach, A. M., et al.
Publicado: (1978)

The characteristics of a canine mammary carcinoma cell line, REM 134.
por: Else, R. W., et al.
Publicado: (1982)

Jagged-2 (JAG2) enhances tumorigenicity and chemoresistance of colorectal cancer cells
por: Vaish, Vivek, et al.
Publicado: (2017)

Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer
por: Zambrano-Estrada, Xóchitl, et al.
Publicado: (2018)

Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance
por: Bessone, Federica, et al.
Publicado: (2021)

Rapamycin Response in Tumorigenic and Non-Tumorigenic Hepatic Cell Lines
por: Jimenez, Rosa H., et al.
Publicado: (2009)

Sorafenib and Doxorubicin Show Synergistic Effects in Human and Canine Osteosarcoma Cell Lines
por: Yang, Ya-Ting, et al.
Publicado: (2022)

Five markers useful for the distinction of canine mammary malignancy
por: Pawłowski, Karol M, et al.
Publicado: (2013)

MDR1 Inhibition Reverses Doxorubicin-Resistance in Six Doxorubicin-Resistant Canine Prostate and Bladder Cancer Cell Lines
por: Packeiser, Eva-Maria, et al.
Publicado: (2023)

Analysis of Contractility and Invasion Potential of Two Canine Mammary Tumor Cell Lines
por: Rajakylä, Kaisa, et al.
Publicado: (2017)

Establishment of a New Cell Line of Canine Mammary Tumor CMT-1026
por: Mei, Chen, et al.
Publicado: (2021)

Doxorubicin Loaded PLGA Nanoparticle with Cationic/Anionic Polyelectrolyte Decoration: Characterization, and Its Therapeutic Potency
por: Tsai, Li-Hui, et al.
Publicado: (2021)

Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells
por: Pagotto, Anna, et al.
Publicado: (2017)

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
por: Zeng, Yunxin, et al.
Publicado: (2021)

Evaluation of a Canine Transmissible Venereal Tumour Cell Line with Tumour Immunity Capacity but Without Tumorigenic Property
por: Zayas, Yareellys Ramos, et al.
Publicado: (2019)

Pleiotrophin promotes chemoresistance to doxorubicin in osteosarcoma by upregulating P-glycoprotein
por: Wu, Dapeng, et al.
Publicado: (2017)

Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma
por: Al-Nadaf, Sami, et al.
Publicado: (2018)

Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines
por: Karai, Edina, et al.
Publicado: (2020)

Granulysin expressed in a humanized mouse model induces apoptotic cell death and suppresses tumorigenicity
por: Hsiao, Ya-Wen, et al.
Publicado: (2016)

Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity
por: Shih, Hung-Ju, et al.
Publicado: (2012)

Identification of tumour-associated and germ line p53 mutations in canine mammary cancer
por: Veldhoen, N, et al.
Publicado: (1999)

Comparative Analysis of the Development of Acquired Radioresistance in Canine and Human Mammary Cancer Cell Lines
por: Gray, Mark, et al.
Publicado: (2020)

Effects of Tyrosine Kinase Inhibitor-masitinib Mesylate on Canine Mammary Tumour Cell Lines
por: Ustun-Alkan, Fulya, et al.
Publicado: (2021)

Establishment and characterization of a multi-drug resistant cell line for canine mammary tumors
por: Zhou, Chaoyu, et al.
Publicado: (2023)

Corrigendum to “Feline mammary carcinoma stem cells are tumorigenic, radioresistant, chemoresistant and defective in activation of the ATM/p53 DNA damage pathway” [The Veterinary Journal 196 (2013) 414–423]
por: Pang, L.Y., et al.
Publicado: (2021)

Metabolomics profiling reveals differences in proliferation between tumorigenic and non-tumorigenic Madin-Darby canine kidney (MDCK) cells
por: Sun, Na, et al.
Publicado: (2023)

Glucose Enhances Pro-Tumorigenic Functions of Mammary Adipose-Derived Mesenchymal Stromal/Stem Cells on Breast Cancer Cell Lines
por: Ambrosio, Maria Rosaria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7s2foou3lo4mkrdd8ekf67hvo9